On 18 June 2020, following CHIL’s export to Belarus, the Belarus Ministry of Health formally acknowledged the quality and performance of CHIL’s diagnostic products with an official letter of appreciation sent to CHIL’s local partner. This recognition highlights CHIL’s commitment to excellence in manufacturing and reinforces the confidence of international partners in the reliability and effectiveness of its solutions.
You may also like
2 months ago
Strategic Technology Transfer
A long-term production and technology transfer agreement with Brazil was signed, reinforcing CHIL’s commitment to sustainable global manufacturing partnerships.
2 years ago
Innovation and Intellectual Property
CHIL initiated patent applications and product development efforts focused on the detection of breast cancer and breast anomalies, signaling a strategic move toward advanced diagnostic technologies.